glp-1 news 2025 october 16 oct What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 Drugs: 6 Things We've – FDA issued 25 warning letters

Whether its a bone that fails to heal swiftly or a fracture that realigns incorrectly, approximately 5-10 % of all fractures are associated with impaired healing [2]

Optimal: noticeable benefits with IGF-1 in target range and few side effects

There is strong evidence from randomised cardiovascular outcome trials (CVOTs) that several long-acting GLP-1 RAs (liraglutide, dulaglutide and subcutaneous semaglutide) provide cardiovascular protection to individuals with T2D with pre-existing cardiovascular disease (secondary prevention) or at high risk of CV events, and to a lesser extent those without overt atherosclerotic vascular disease (primary prevention

For some people, an injection makes more sense because it makes nutrients such as vitamin B12, other B vitamins and magnesium much more available

A licensed Fitish provider reviews every intake